Medicure Inc (MCUJF) stock
MCUJFOTCPharmaceutical PreparationsFiscal year ends December 31
$3.10+0.12 (+4.07%)
Close on Oct 19, 2026
Medicure EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -0.68 CAD. The highest annual figure on record is 2.39 CAD in fiscal 2017.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -0.68 CAD | – |
| FY2024 | Dec 31, 2024 | -0.10 CAD | – |
| FY2023 | Dec 31, 2023 | -0.09 CAD | -169.2% |
| FY2022 | Dec 31, 2022 | 0.13 CAD | – |
| FY2021 | Dec 31, 2021 | -0.07 CAD | – |
| FY2020 | Dec 31, 2020 | -0.64 CAD | – |
| FY2019 | Dec 31, 2019 | -1.32 CAD | -650.0% |
| FY2018 | Dec 31, 2018 | 0.24 CAD | -90.0% |
| FY2017 | Dec 31, 2017 | 2.39 CAD | +53.2% |
| FY2016 | Dec 31, 2016 | 1.56 CAD | +1318.2% |
| FY2015 | Dec 31, 2015 | 0.11 CAD | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -0.07 CAD | – |
| Q1 FY2024 | Mar 31, 2024 | 0.00 CAD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?